Mubadala enters into a definitive deal to acquire KELIX bio
25 Mar 2024
Mubadala Investment Company (Mubadala), an Abu Dhabi sovereign investor, has entered into a definitive agreement to acquire KELIX bio, a specialty pharmaceutical business focused on delivering complex generics across emerging...